Skip to main content
. 2024 Mar 20;14:1368732. doi: 10.3389/fonc.2024.1368732

Table 1.

FDA approved CAR-T cell therapy products.

CAR-T Name Target Indications Time to market Reference
Kymriah CD19 BCR-AL/rr DLBCL 2017.08.30 Maude Slet al. (19)
Yescarta CD19 rr DLBCL/rr FL 2017.10.18 Locke FL et al. (20)
Tecartus CD19 rr MCL 2020.07.24 Wang M et al. (21)
Breyanzi CD19 rr DLBCL 2021.02.05 Abramson JS et al. (22)
Abecma BCMA rr MM 2021.03.26 Berdeja JG et al. (23)
Carvykti BCMA rr MM 2022.02.28 Munshi NC et al. (24)